Journal article
Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and RAS pathway aberrations
SM Hunter, KL Gorringe, M Christie, SM Rowley, DD Bowtell, IG Campbell
Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2012
Abstract
Introduction: Mucinous tumors are the second most common form of epithelial ovarian tumor, yet the cell of origin for this histologic subtype remains undetermined. Although these tumors are thought to arise through a stepwise progression from benign cystadenoma to borderline tumor to invasive carcinoma, few studies have attempted to comprehensively characterize the genetic changes specific to this subtype or its precursors. Methods: To explore the spectrum of genomic alterations common to mucinous tumors we carried out high-resolution genome-wide copy number analysis, mutation screening by Sanger sequencing and immunohistochemistry on a series of primary ovarian mucinous cystadenomas (n = 20..
View full abstractGrants
Awarded by National Health & Medical Research Council of Australia (NHMRC)
Awarded by U.S. Army Medical Research and Materiel Command
Awarded by National Health and Medical Research Council of Australia (NHMRC)
Funding Acknowledgements
This study was supported by the Victorian Breast Cancer Research Consortium (VBCRC) and the National Health & Medical Research Council of Australia (NHMRC, ID 628630) and the Emer Casey Foundation. The AOCS was supported by the U.S. Army Medical Research and Materiel Command under DAMD17-01-1-0729, The Cancer Council Tasmania and The Cancer Foundation of Western Australia and the National Health and Medical Research Council of Australia (NHMRC; ID400413).